Tennessee Oncology, Sarah Canon Research Institute — Nashville, Tennessee

Tennessee Oncology, Sarah Canon Research Institute is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology, Sarah Canon Research Institute has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors, Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter.

Sponsors: Principia Biopharma, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology, Sarah Canon Research Institute?

Tennessee Oncology, Sarah Canon Research Institute has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology, Sarah Canon Research Institute conducted?

Tennessee Oncology, Sarah Canon Research Institute has 1 clinical trials on record. Their work covers Solid Tumors, Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter.

Is Tennessee Oncology, Sarah Canon Research Institute accredited by Crixeo Health?

Tennessee Oncology, Sarah Canon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology, Sarah Canon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.